Evaluation of a Risk Screening Tool for Retinopathy of Prematurity (ROP) in a German Cohort

N Butt1, P Chlad2, A Bläser1

  • 1Department of Neonatology, Leipzig University, Leipzig, Germany.

Ophthalmic Epidemiology
|December 18, 2024
PubMed

Insights

The DIGIROP-Birth algorithm effectively identifies infants at risk for retinopathy of prematurity (ROP). Incorporating peri- and postnatal factors improves ROP screening accuracy for preterm infants.

Area of Science:

  • Ophthalmology
  • Neonatology
  • Medical Informatics

Background:

  • Retinopathy of prematurity (ROP) is a leading cause of visual impairment in preterm infants.
  • Early identification of infants at risk for ROP is crucial for timely intervention and prevention of vision loss.
  • Existing screening methods may benefit from enhanced predictive algorithms.

Purpose of the Study:

  • To evaluate the predictive efficacy of the DIGIROP-Birth algorithm for identifying infants at risk of developing retinopathy of prematurity (ROP).
  • To assess the performance of the DIGIROP-Birth calculator in a cohort of preterm infants.

Main Methods:

  • Retrospective analysis of 897 preterm infants (24 0/7 to 30 6/7 weeks gestational age) from 2010-2020.
  • Validation of the DIGIROP-Birth algorithm using receiver-operating characteristic (ROC) curves.
  • Calculation of area under the curve (AUC), sensitivity, specificity, and predictive values.

Main Results:

  • The DIGIROP-Birth algorithm demonstrated good predictive power with an AUC of 0.860 for ROP requiring treatment.
  • Sensitivity and specificity equilibrium was observed at a 4.12% probability threshold.
  • Negative predictive value was high at 99.36%, indicating effective identification of infants not requiring treatment.
  • Identified emergency cesarean section and mass blood transfusions as significant independent risk factors.

Conclusions:

  • The DIGIROP-Birth calculator exhibits strong predictive capabilities for therapy-requiring ROP in the studied preterm infant population.
  • The incidence of therapy-requiring ROP in the cohort was 3.79%.
  • Integrating peri- and postnatal risk factors into ROP screening protocols is recommended for improved clinical outcomes.
Abstract

Related Concept Videos